These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Acute myocardial infarction with sumatriptan: a case report and review of the literature. Chalaupka FD Headache; 2009 May; 49(5):762-4. PubMed ID: 19456882 [TBL] [Abstract][Full Text] [Related]
8. Migraine, eating disorders, and triptans: an unrecognized risk? Wilkinson F Headache; 2001 Oct; 41(9):914-5. PubMed ID: 11703486 [No Abstract] [Full Text] [Related]
11. A study of the effects of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH3 positron emission tomography. Lewis PJ; Barrington SF; Marsden PK; Maisey MN; Lewis LD Neurology; 1997 Jun; 48(6):1542-50. PubMed ID: 9191764 [TBL] [Abstract][Full Text] [Related]
12. Coronary side-effect potential of current and prospective antimigraine drugs. MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078 [TBL] [Abstract][Full Text] [Related]
14. Cerebral vasospasm from sumatriptan. Dash S; Bogdanova O; Xavier A; Farkas J; Pullicino P Neurology; 2004 Dec; 63(11):2128. PubMed ID: 15596760 [No Abstract] [Full Text] [Related]
15. QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case. Stillman MJ; Tepper S; Tepper DE; Cho L Headache; 2013 Jan; 53(1):208-216. PubMed ID: 23216317 [TBL] [Abstract][Full Text] [Related]
17. ST-Elevation Myocardial Infarction After Sumitriptan Ingestion in Patient with Normal Coronary Arteries. Jensen C; Riddle M West J Emerg Med; 2015 Sep; 16(5):781-3. PubMed ID: 26587110 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation. Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821 [TBL] [Abstract][Full Text] [Related]
19. [Use of triptanes according to indications. Risk of infarct is not increased]. MMW Fortschr Med; 2004 Feb; 146(7):60. PubMed ID: 15347059 [No Abstract] [Full Text] [Related]
20. [Choice of triptan in migraine]. Salvesen R Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3410-1. PubMed ID: 11826788 [No Abstract] [Full Text] [Related] [Next] [New Search]